Clinical manifestations of mutations associated with TRAPPC9 include ID, developmental delay, microcephaly, brain abnormalities, dysmorphic facial features, and obesity have been reported in previous studies (Table 1). Here, TRAPPC9 is linked to obesity due to melanocortin 4 receptor deficiency.